News Transactions under Novozymes’ stock buyback program Staff February 15, 2021 Please read the full announcement in the attached PDF Attachment 2021_07_Stock_Buybackprogram Iframe sync Post navigation Previous: Synairgen announces that dosing has commenced with its inhaled interferon beta product in US Government-funded NIH ACTIV-2 trial in COVID-19 outpatientsNext: Alimera Sciences to Present at the Microcap Rodeo Winter Wonderland Conference More Stories Healthcare News Pharmaceutical CannaPharmaRX Provides Corporate Update and Outlines Growth Strategy for 2026 Staff January 12, 2026 Healthcare News TempraMed Closes C$2.5 Million Fully Subscribed Private Placement Staff January 12, 2026 Mental Health News TruuCONNECT NJ Statewide Digital Hub Empowers Users to Find Verified, Local Community Resources and Support – Anonymously and in Real Time Staff January 12, 2026
